[
  {
    "ts": null,
    "headline": "Abbott Laboratories Still Offers Attractive Valuation, UBS Says",
    "summary": "Abbott Laboratories' (ABT) diabetes, electrophysiology, and structural heart businesses' growth outl",
    "url": "https://finnhub.io/api/news?id=accb740cf4f252c19d1f4295d1dbb44b7b00da1673319777591debedaf84e5c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759947267,
      "headline": "Abbott Laboratories Still Offers Attractive Valuation, UBS Says",
      "id": 137012963,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Abbott Laboratories' (ABT) diabetes, electrophysiology, and structural heart businesses' growth outl",
      "url": "https://finnhub.io/api/news?id=accb740cf4f252c19d1f4295d1dbb44b7b00da1673319777591debedaf84e5c9"
    }
  },
  {
    "ts": null,
    "headline": "Revolutionizing Cardiology: Robots, AI, and Innovations at the Heart of Change",
    "summary": "The next-generation intervention cardiology sector is experiencing a transformative shift, leveraging precision-guided, minimally invasive techniques to address complex cardiovascular conditions like coronary artery disease and structural heart defects. This field integrates robotics, AI-powered imaging, and advanced devices, marking a significant move away from traditional open-heart surgeries. With the market projected to reach $46.82 billion by 2035, key players including Abbott, Medtronic, a",
    "url": "https://finnhub.io/api/news?id=085affccf98d8f236a1968cd463ac8ad784e85caaaba4a51236bf5de86a399e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759923960,
      "headline": "Revolutionizing Cardiology: Robots, AI, and Innovations at the Heart of Change",
      "id": 137010062,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The next-generation intervention cardiology sector is experiencing a transformative shift, leveraging precision-guided, minimally invasive techniques to address complex cardiovascular conditions like coronary artery disease and structural heart defects. This field integrates robotics, AI-powered imaging, and advanced devices, marking a significant move away from traditional open-heart surgeries. With the market projected to reach $46.82 billion by 2035, key players including Abbott, Medtronic, a",
      "url": "https://finnhub.io/api/news?id=085affccf98d8f236a1968cd463ac8ad784e85caaaba4a51236bf5de86a399e1"
    }
  },
  {
    "ts": null,
    "headline": "2 S&P 500 Stocks to Target This Week and 1 Facing Challenges",
    "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
    "url": "https://finnhub.io/api/news?id=0b252416d18d66e953b01c8fa1616cc74e62f385c4e8c99d9a460996dfcecaa2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759898115,
      "headline": "2 S&P 500 Stocks to Target This Week and 1 Facing Challenges",
      "id": 137010134,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
      "url": "https://finnhub.io/api/news?id=0b252416d18d66e953b01c8fa1616cc74e62f385c4e8c99d9a460996dfcecaa2"
    }
  },
  {
    "ts": null,
    "headline": "Evercore ISI Group Maintains Boston Scientific (BSX) Outperform Recommendation",
    "summary": "Evercore ISI Group Maintains Boston Scientific (BSX) Outperform Recommendation",
    "url": "https://finnhub.io/api/news?id=b59a7576de87333433679b4ab52d3f94908a0d69cd6536b334636801b609afc0",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759881903,
      "headline": "Evercore ISI Group Maintains Boston Scientific (BSX) Outperform Recommendation",
      "id": 137005025,
      "image": "",
      "related": "BSX",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b59a7576de87333433679b4ab52d3f94908a0d69cd6536b334636801b609afc0"
    }
  }
]